Weekly Wrap: Monsanto Worries Leave Bayer Looking Cheap
Concerns that Bayer will overpay for the ag giant have created an opportunity. Plus, why we like defense contractor moats.
Jeremy Glaser: Should Bayer shareholders be worried? Is there value in defense? And how one tech giant is planning on becoming more focused. This time on the Morningstar Weekly Wrap.
After a few weeks of speculation, we got Bayer's formal offer for Monsanto this week. Monsanto rejected it, but said they were open to further negotiations. Does this mean Bayer's going to have overpay to take over the agriculture giant and what does this mean for Bayer shareholders? Damien Conover shares his thoughts.
Jeremy Glaser does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.